Market Cap 58.14M
Revenue (ttm) 0.00
Net Income (ttm) -12.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,600
Avg Vol 33,650
Day's Range N/A - N/A
Shares Out 4.98M
Stochastic %K 39%
Beta 0.47
Analysts Strong Sell
Price Target $39.00

Company Profile

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab and balstilima...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 994 8250
Address:
149 Fifth Avenue, Suite 500, New York, United States
OrientBeach
OrientBeach Jul. 4 at 5:24 PM
$INKT Just to make a correction. Everglade is a solicitation agent for BARDA and NOT the name of BARDA’s ARDS program
0 · Reply
OrientBeach
OrientBeach Jul. 3 at 4:00 PM
$INKT It would certainly appears as if Mink’s Agent-797 has been enrolled into BARDA’s Everglades ARDS program. The Responses Deadline was April 15th and Mink’s Lviv trial started May 14th. I have been following the candidates since ‘23 when the ARDS program was once called DRIVe. Rigel’s Fostamatinib drug is also a candidate, and their trial is scheduled to start in August. Rigel received $750.0K in funds to further study Fostamatinib back in Sept ‘23. I am not a scientist so I am unable to speculate on which drug is better https://everglade.com/barda-rfi-on-host-directed-therapeutics-for-ards-prevention/
1 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 9:02 PM
$INKT Just need a spark!
0 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 5:31 PM
$INKT Hoping for Ibrx affiliation boost. We will see.
1 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 12:01 PM
$INKT Car T Cell therapy on Fox News. Mink involved in this therapy and only a matter of time before people realize this.
0 · Reply
BioinvestorUSA
BioinvestorUSA Jun. 30 at 1:17 PM
$INKT smart person
0 · Reply
Tigertkbc
Tigertkbc Jun. 28 at 7:22 PM
$INKT Just you and I but our day will be coming and hopefully soon!
1 · Reply
Dancady1
Dancady1 Jun. 26 at 9:02 PM
$INKT anyone here ?
1 · Reply
Tigertkbc
Tigertkbc Jun. 17 at 1:56 PM
$INKT Read the transcript from meeting this morning. Exciting!
2 · Reply
Dancady1
Dancady1 Jun. 12 at 12:45 PM
$INKT come on to the moon inkt since we have not gone to zero we still have the science. Every day every week that passes by draws us closer to 1 billion -5billion market cap
1 · Reply
Latest News on INKT
MiNK Therapeutics Transcript: AGM 2026

Jun 17, 2026, 9:30 AM EDT - 17 days ago

MiNK Therapeutics Transcript: AGM 2026


MiNK Therapeutics doses first patient in agenT-797 trial

2026-05-28T14:12:03.000Z - 5 weeks ago

MiNK Therapeutics doses first patient in agenT-797 trial


MiNK Therapeutics reports new data on agenT-797 at ATS 2026

2026-05-20T15:15:48.000Z - 6 weeks ago

MiNK Therapeutics reports new data on agenT-797 at ATS 2026


MiNK Therapeutics Earnings Call Transcript: Q1 2026

May 15, 2026, 8:30 AM EDT - 7 weeks ago

MiNK Therapeutics Earnings Call Transcript: Q1 2026


MiNK Therapeutics Earnings release: Q1 2026

May 15, 2026, 8:30 AM EDT - 7 weeks ago

MiNK Therapeutics Earnings release: Q1 2026


MiNK Therapeutics Quarterly report: Q1 2026

May 15, 2026, 8:30 AM EDT - 7 weeks ago

MiNK Therapeutics Quarterly report: Q1 2026


MiNK Therapeutics initiates agenT-797 clinical trial

2026-05-14T17:31:11.000Z - 7 weeks ago

MiNK Therapeutics initiates agenT-797 clinical trial


MiNK Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

MiNK Therapeutics Proxy statement: Proxy filing


MiNK Therapeutics management to meet virtually with B. Riley

2026-04-20T17:05:20.000Z - 2 months ago

MiNK Therapeutics management to meet virtually with B. Riley


MiNK Therapeutics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 8:30 AM EDT - 3 months ago

MiNK Therapeutics Earnings Call Transcript: Q4 2025


MiNK Therapeutics Annual report: Q4 2025

Mar 31, 2026, 8:30 AM EDT - 3 months ago

MiNK Therapeutics Annual report: Q4 2025


MiNK Therapeutics Earnings release: Q4 2025

Mar 31, 2026, 8:30 AM EDT - 3 months ago

MiNK Therapeutics Earnings release: Q4 2025


3 Penny Stocks to Watch Now, 3/11/26

2026-03-11T14:11:00.000Z - 4 months ago

3 Penny Stocks to Watch Now, 3/11/26

ATPC LGVN


Why Is MiNK Therapeutics Stock (INKT) Up Today?

2026-03-10T12:33:59.000Z - 4 months ago

Why Is MiNK Therapeutics Stock (INKT) Up Today?


MiNK Therapeutics Registration statement: Registration Filing

Dec 10, 2025, 7:00 AM EST - 7 months ago

MiNK Therapeutics Registration statement: Registration Filing


MiNK Therapeutics Earnings Call Transcript: Q3 2025

Nov 14, 2025, 8:30 AM EST - 8 months ago

MiNK Therapeutics Earnings Call Transcript: Q3 2025


MiNK Therapeutics Quarterly report: Q3 2025

Nov 14, 2025, 8:30 AM EST - 8 months ago

MiNK Therapeutics Quarterly report: Q3 2025


MiNK Therapeutics Earnings release: Q3 2025

Nov 14, 2025, 8:30 AM EST - 8 months ago

MiNK Therapeutics Earnings release: Q3 2025


MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year

2025-11-14T12:35:56.000Z - 8 months ago

MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year


MiNK Therapeutics files $150M mixed securities shelf

2025-11-07T22:00:18.000Z - 8 months ago

MiNK Therapeutics files $150M mixed securities shelf


MiNK Therapeutics reports updated clinical results on agenT-797

2025-11-07T14:05:54.000Z - 8 months ago

MiNK Therapeutics reports updated clinical results on agenT-797


MiNK Therapeutics Registration statement: Registration Filing

Nov 7, 2025, 7:00 AM EST - 8 months ago

MiNK Therapeutics Registration statement: Registration Filing


MiNK Therapeutics appoints John Holcomb to board of directors

2025-09-29T11:45:50.000Z - 9 months ago

MiNK Therapeutics appoints John Holcomb to board of directors


MiNK Therapeutics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 11 months ago

MiNK Therapeutics Earnings Call Transcript: Q2 2025


MiNK Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 11 months ago

MiNK Therapeutics Quarterly report: Q2 2025


MiNK Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 11 months ago

MiNK Therapeutics Earnings release: Q2 2025


MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year

2025-08-14T11:40:29.000Z - 11 months ago

MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year


MiNK Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Earnings Call Transcript: Q1 2025


MiNK Therapeutics Quarterly report: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Quarterly report: Q1 2025


MiNK Therapeutics Earnings release: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Earnings release: Q1 2025


MiNK Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

MiNK Therapeutics Proxy statement: Proxy Filing


MiNK Therapeutics Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

MiNK Therapeutics Proxy statement: Proxy Filing


MiNK Therapeutics Earnings Call Transcript: Q4 2024

Mar 18, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Earnings Call Transcript: Q4 2024


MiNK Therapeutics Annual report: Q4 2024

Mar 18, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Annual report: Q4 2024


MiNK Therapeutics Earnings release: Q4 2024

Mar 18, 2025, 8:30 AM EDT - 1 year ago

MiNK Therapeutics Earnings release: Q4 2024


MiNK Therapeutics Proxy statement: Proxy Filing

Dec 20, 2024, 7:00 AM EST - 1 year ago

MiNK Therapeutics Proxy statement: Proxy Filing


MiNK Therapeutics Proxy statement: Proxy Filing

Dec 6, 2024, 7:00 AM EST - 1 year ago

MiNK Therapeutics Proxy statement: Proxy Filing


MiNK Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

MiNK Therapeutics Earnings Call Transcript: Q3 2024


MiNK Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

MiNK Therapeutics Quarterly report: Q3 2024


MiNK Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 8:30 AM EST - 1 year ago

MiNK Therapeutics Earnings release: Q3 2024


MiNK Therapeutics Earnings Call Transcript: Q2 2024

Aug 13, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings Call Transcript: Q2 2024


MiNK Therapeutics Quarterly report: Q2 2024

Aug 13, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Quarterly report: Q2 2024


MiNK Therapeutics Earnings release: Q2 2024

Aug 13, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings release: Q2 2024


MiNK Therapeutics Registration statement: Registration Filing

Aug 13, 2024, 8:00 AM EDT - 2 years ago

MiNK Therapeutics Registration statement: Registration Filing


MiNK Reports Second Quarter 2024 Results and Business Update

Aug 13, 2024, 7:00 AM EDT - 2 years ago

MiNK Reports Second Quarter 2024 Results and Business Update


MiNK Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings Call Transcript: Q1 2024


MiNK Therapeutics Quarterly report: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Quarterly report: Q1 2024


MiNK Therapeutics Earnings release: Q1 2024

May 14, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings release: Q1 2024


MiNK Reports First Quarter 2024 Results

May 14, 2024, 7:30 AM EDT - 2 years ago

MiNK Reports First Quarter 2024 Results


MiNK Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

MiNK Therapeutics Proxy statement: Proxy Filing


MiNK Therapeutics Earnings Call Transcript: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings Call Transcript: Q4 2023


MiNK Therapeutics Annual report: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Annual report: Q4 2023


MiNK Therapeutics Earnings release: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

MiNK Therapeutics Earnings release: Q4 2023


MiNK Reports Fourth Quarter and Year-End 2023 Results

Mar 21, 2024, 7:00 AM EDT - 2 years ago

MiNK Reports Fourth Quarter and Year-End 2023 Results


OrientBeach
OrientBeach Jul. 4 at 5:24 PM
$INKT Just to make a correction. Everglade is a solicitation agent for BARDA and NOT the name of BARDA’s ARDS program
0 · Reply
OrientBeach
OrientBeach Jul. 3 at 4:00 PM
$INKT It would certainly appears as if Mink’s Agent-797 has been enrolled into BARDA’s Everglades ARDS program. The Responses Deadline was April 15th and Mink’s Lviv trial started May 14th. I have been following the candidates since ‘23 when the ARDS program was once called DRIVe. Rigel’s Fostamatinib drug is also a candidate, and their trial is scheduled to start in August. Rigel received $750.0K in funds to further study Fostamatinib back in Sept ‘23. I am not a scientist so I am unable to speculate on which drug is better https://everglade.com/barda-rfi-on-host-directed-therapeutics-for-ards-prevention/
1 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 9:02 PM
$INKT Just need a spark!
0 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 5:31 PM
$INKT Hoping for Ibrx affiliation boost. We will see.
1 · Reply
Tigertkbc
Tigertkbc Jul. 1 at 12:01 PM
$INKT Car T Cell therapy on Fox News. Mink involved in this therapy and only a matter of time before people realize this.
0 · Reply
BioinvestorUSA
BioinvestorUSA Jun. 30 at 1:17 PM
$INKT smart person
0 · Reply
Tigertkbc
Tigertkbc Jun. 28 at 7:22 PM
$INKT Just you and I but our day will be coming and hopefully soon!
1 · Reply
Dancady1
Dancady1 Jun. 26 at 9:02 PM
$INKT anyone here ?
1 · Reply
Tigertkbc
Tigertkbc Jun. 17 at 1:56 PM
$INKT Read the transcript from meeting this morning. Exciting!
2 · Reply
Dancady1
Dancady1 Jun. 12 at 12:45 PM
$INKT come on to the moon inkt since we have not gone to zero we still have the science. Every day every week that passes by draws us closer to 1 billion -5billion market cap
1 · Reply
Ralph_Kramden_1
Ralph_Kramden_1 Jun. 10 at 6:24 PM
$INKT Added 1k
0 · Reply
Outcomes
Outcomes Jun. 2 at 8:11 PM
$INKT ….Form 4s
2 · Reply
Dancady1
Dancady1 Jun. 2 at 6:49 PM
$INKT is it going to pop…??
0 · Reply
Spartrap
Spartrap Jun. 1 at 10:14 PM
$INKT it feels like this is briskly moving from the 'trading vehicle' category just worthy of a scalp or two, to the 'great investment idea' category
1 · Reply
Spartrap
Spartrap Jun. 1 at 2:02 PM
$INKT one just needed to listen to the call last quarter. Hammond was so eloquent and full of passion, very different from the usual. It was obvious something big was going on. I tripled my position after that. Always listen to calls, transcripts don't convey the nuances
1 · Reply
2_logs_higher
2_logs_higher May. 31 at 8:49 PM
$AGEN & $INKT when INKT does a PR it literally says dosed our first patient for phase P2. When reading the AGEN PR, it states recruiting. When ask Zack about this, he says it would be immoral for us to recruit and not dose. An immediate follow up was sent, and asked,have you dosed, no response. I continue to say they’re recruiting and then filtering the best possible candidates who may or may not actually be dosed. at the end of Q2, we will get some flim flam flab a dab jibber jabber response from IR on why it’s being delayed. we’re saving millions by restructuring our approach
2 · Reply
iso
iso May. 28 at 6:36 PM
$INKT 10× might be Sooner.. especially after big news, stock adviser on it on YouTube
0 · Reply
iso
iso May. 28 at 5:33 PM
$INKT great,i lovevit
0 · Reply
Turnthemachinesbackon
Turnthemachinesbackon May. 28 at 5:22 PM
$INKT https://x.com/alc2022/status/2059946096915276145?s=20
0 · Reply
Quantcompass
Quantcompass May. 28 at 5:09 PM
$INKT With 3.5 quarters of cash runway the dilution here is real. Its as binary as bets can get.
0 · Reply
Quantcompass
Quantcompass May. 28 at 5:06 PM
$INKT Theres a second wave of shorts that follow antonios shills beware
0 · Reply
ultramit
ultramit May. 28 at 4:55 PM
$INKT well.. Antonio shilling this and peoples are buying. Lol
0 · Reply